IP Library › Assignment 015139/0294
Patent Assignment
Reel/Frame 015139/0294

Assignment of Assignor's Interest

Recorded: 2004-09-15 Pages: 31
Assignor
HYAL PHARMACEUTICAL CORPORATION
Executed: 1999-08-16
Assignee
PRICEWATERHOUSECOOPERS INC.
145 KING STREET WEST, (INTERIM RECEIVER OF HYAL PHARMACEUTICAL CORPORATION), TORONTO, ONTARIO M5H 1V8, CANADA
Covered Properties (50)
Pure, Sterile, Pyrogen-Free Hyaluronic Acid Formulations Their Methods of Preparation and Methods of Use
Patent: 5,079,236 →
Application: 07/054,859 →
Method for Treating Equine Navicular Disease with Pentoxifylline, and Composition Containing Pentoxifylline for Administrating to Horses
Patent: 5,077,296 →
Application: 07/128,175 →
Immune Cell Proliferation Inhibitors
Patent: 5,039,521 →
Application: 07/295,734 →
The Use of Hyaluronic Acid or Its Derivatives to Enhance Delivery of Therapeutic Agents
Patent: 6,069,135 →
Application: 07/675,908 →
Immune Cell Proliferation Inhibitors
Patent: 5,256,411 →
Application: 07/720,591 →
Treatment of Basal Cell Carcinoma and Actinic Keratosis Employing Hyaluronic Acid and Nsaids
Patent: 5,639,738 →
Application: 07/838,675 →
Treatment of Disease Employing Hyaluronic Acid and Nsaids
Patent: 5,792,753 →
Application: 08/018,508 →
Therapeutic Methods Using Hyaluronic Acid
Patent: 6,103,704 →
Application: 08/018,754 →
Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis
Patent: 5,834,444 →
Application: 08/125,398 →
Use of Hyaluronic Acid to Repair Ischemia Reperfusion Damage
Patent: 5,674,857 →
Application: 08/200,309 →
Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis
Patent: 5,614,506 →
Application: 08/285,764 →
A Method of Using Hyaluronic Acid or Its Pharmaceutically Acceptable Salts for the Treatment of Disease
Patent: 5,827,834 →
Application: 08/286,263 →
Topical Composition Containing Hyaluronic Acid and Nsaids
Patent: 5,910,489 →
Application: 08/290,848 →
Treatment of Disease and Conditions Associated with Macrophage Infiltration
Patent: 5,767,106 →
Application: 08/295,390 →
Formulations Containing Hyaluronic Acid
Patent: 6,114,314 →
Application: 08/352,697 →
Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis
Patent: 6,022,866 →
Application: 08/403,766 →
Use of Hyalufonic Acid and Forms to Prevent Arterial Restenosis
Patent: 5,990,095 →
Application: 08/448,503 →
Treatment of Conditions and Disease
Patent: 6,194,392 →
Application: 08/460,978 →
Compositions, for Inhibition, Control and Regression of Angiogenesis, Containing Hyaluronic Acid and Nsaid
Patent: 5,847,002 →
Application: 08/461,123 →
Treatment of Conditions and Disease
Patent: 5,932,560 →
Application: 08/461,124 →
Treatment of Conditions and Disease
Patent: 6,048,844 →
Application: 08/461,565 →
Treatment of Conditions and Disease
Patent: 5,852,002 →
Application: 08/462,147 →
Treatment of Conditions and Disease
Patent: 5,929,048 →
Application: 08/462,148 →
Compositions Comprising Hyaluronic Acid and Drugs
Patent: 5,985,850 →
Application: 08/462,154 →
The Use of a Form of Hyaluronic Acid and a Medicinal Agent for Reducing Rejection of Organs Transplantation in Mammals
Patent: 5,914,314 →
Application: 08/462,614 →
Compositions Containing a Form of Hyaluronic Acid and a Medicinal Agent for Treating Acne in Mammals and Methods for Administration of Such Composition
Patent: 5,830,882 →
Application: 08/462,615 →
Clearing of Atherosclerosis
Patent: 5,817,642 →
Application: 08/464,769 →
A Method of Administering of a Hyaluronic Acid and an Nsaid to Decrease Side Effects of the Nsaid
Patent: 5,811,410 →
Application: 08/465,335 →
Formulations Containing Hyaluronic Acid
Patent: 5,990,096 →
Application: 08/466,713 →
Formulations Containing Hyaluronic Acid
Patent: 6,140,312 →
Application: 08/466,714 →
Formulations Containing Hyaluronic Acid
Patent: 6,136,793 →
Application: 08/466,715 →
Treatment of Disease and Conditions
Patent: 5,914,322 →
Application: 08/466,774 →
Topical Composition Containing Hyaluronic Acid and Nsaids
Patent: 6,017,900 →
Application: 08/466,775 →
Topical Composition Containing Hyaluronic Acid and Nsaids
Patent: 5,962,433 →
Application: 08/466,778 →
Formulations Containing Hyaluronic Acid
Patent: 5,942,498 →
Application: 08/467,171 →
Formulations Containing Hyaluronic Acid
Patent: 6,218,373 →
Application: 08/467,994 →
Formulations Containing Hyaluronic Acid
Patent: 5,977,088 →
Application: 08/467,995 →
Topical Composition Containing Hyaluronic Acid and Nsaids
Patent: 5,824,658 →
Application: 08/468,329 →
Formulations Containing Hyaluronic Acid
Patent: 6,147,059 →
Application: 08/468,330 →
Formulations Containing Hyaluronic Acid
Patent: 6,087,344 →
Application: 08/474,732 →
Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain Thereof
Patent: 5,972,906 →
Application: 08/503,919 →
Targeting of Dosages of Medicine and Therapeutic Agents
Patent: 5,817,644 →
Application: 08/568,489 →
The Use of Hyaluronic Acid or Its Derivatives in Peritoneal Dialysis and Formulations Thereof
Patent: 5,985,851 →
Application: 08/744,852 →
Fructan-Containing Baby Food Compositions and Methods Therefor
Patent: 5,840,361 →
Application: 08/838,673 →
Use of Hyaluronan in Gene Therapy
Patent: 6,475,795 →
Application: 08/860,696 →
Promotion of Wound Healing Utilizing Steroids Having Reduced Deteriorous Systemic Side Effects Typical of Glucocorticoids, Mineralocorticoids and Sex Steroids
Patent: 6,596,703 →
Application: 08/893,620 →
Use of Hyaluronic Acid and a Nsaid for the Manufacture of a Medicament for the Treatment of Mucosal Diseases
Patent: 6,159,955 →
Application: 08/981,602 →
Use of Hyaluronic Acid and Forms to Prevent the Narrowing of the Vascular Walls
Patent: 6,852,708 →
Application: 08/996,470 →
Publication: US 2002/0077314
Oral Administration of Effective Amounts of Forms of Hyaluronic Acid
Patent: 6,537,978 →
Application: 09/101,286 →
Hyaluronic Drug Delivery System
Patent: 6,890,901 →
Application: 09/269,529 →
Publication: US 2001/0005501
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Jul 10, 1987
From: DRIZEN, ALAN; AVIAD, ANITA
To: STERIVET LABORATORIES, INC., 3909 NASHUA DR., MISSISSAUGA, ONTARIO, CANADA L4V 1R3 A CORP. OF CANADA
Reel/Frame 004736/0279 →
Assignment of Assignors Interest. Dec 3, 1987
From: DRIZEN, ALAN
To: STERIVET LABORATORIES LIMITED, 3909 NASHUA DRIVE, MISSISSAUGA, ONTARIO, CANADA L4V 1R3, A CORP. OF CANADA
Reel/Frame 004798/0569 →
Assignment of Assignors Interest. Mar 13, 1989
From: BOLTON, ANTHONY E.; DRIZEN, ALAN
To: STERIVET LABORATORIES LIMITED
Reel/Frame 005053/0860 →
Change of Name May 9, 1990 Apr 12, 1991
From: STERIVET LABORATORIES LIMITED
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 005662/0730 →
Assignment of Assignors Interest. Jul 3, 1991
From: FALK, RUDOLF E.; ASCULAI, SAMUEL S.
To: NORPHARMCO, INC., A CORP. OF CANADA
Reel/Frame 006254/0949 →
Assignment of Assignors Interest. Apr 3, 1992
From: BOLTON, ANTHONY E.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 006066/0766 →
Assignment of Assignors Interest. Apr 3, 1992
From: BOLTON, ANTHONY E.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 006066/0769 →
Assignment of Assignors Interest. Sep 30, 1992
From: FALK, RUDOLF E.
To: NORPHARMCO INC.
Reel/Frame 006294/0324 →
Assignment of Assignors Interest. Sep 30, 1992
From: ASCULAI, SAMUEL S.
To: NORPHARMCO INC.
Reel/Frame 006294/0326 →
Assignment of Assignors Interest. Nov 2, 1992
From: HYAL PHARMACEUTICAL CORPORATION
To: INTERMUNE LIFE SCIENCES, INC.
Reel/Frame 006289/0777 →
Appointment of Associate Agent Dec 18, 1992
From: FALK, RUDOLF E.; ASCULAI, SAMUEL S.; NORPHARMCO INC.
To: HUGHES ETIGSON
Reel/Frame 006385/0800 →
Assignment of Assignor's Interest Jan 20, 1995
From: NORPHARMCO, INC.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 007325/0147 →
Assignment of Assignor's Interest Jan 20, 1995
From: NORPHARMCO, INC.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 007325/0150 →
Assignment of Assignor's Interest Jan 20, 1995
From: NORPHARMCO, INC.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 007325/0153 →
Assignment of Assignor's Interest Jan 20, 1995
From: NORPHARMCO, INC.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 007316/0384 →
Assignment of Assignor's Interest Jan 20, 1995
From: NORPHARMCO, INC.
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 007331/0836 →
Security Agreement Dec 28, 1995
From: INTERMUNE LIFE SCIENCES INC.
To: HELIX(PEI) INC.
Reel/Frame 007749/0881 →
Assignment of Assignor's Interest Jun 3, 1996
From: HYAL PHARMECEUTICAL CORPORATION
To: SANOFI SANTE ANIMALE, CANADA, INC.
Reel/Frame 007961/0664 →
Merger Jun 4, 1996
From: SANOFI SANTE ANIMALE, CANADA, INC.
To: RHONE MERIEUX, CANADA, INC.
Reel/Frame 007986/0062 →
Assignment of Assignor's Interest Nov 12, 1997
From: FALK, RUDOLF EDGAR
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008806/0488 →
Assignment of Assignor's Interest Nov 12, 1997
From: ASCULAI, SAMUEL SIMON
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008806/0479 →
Assignment of Assignor's Interest Nov 21, 1997
From: FALK, RUDOLF EDGAR
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008859/0640 →
Assignment of Assignor's Interest Nov 21, 1997
From: ASCULAI, SAMUEL SIMON
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008859/0632 →
Assignment of Assignor's Interest Dec 22, 1997
From: TURLEY, EVA ANNE
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008882/0067 →
Assignment of Assignor's Interest Dec 22, 1997
From: ASCULAI, SAMUEL SIMON
To: HYAL PHARMACEUTICAL CORPORATION
Reel/Frame 008881/0917 →